| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 07/04/2007 | EP1569636A4 Use of equol for treating androgen mediated diseases |
| 07/04/2007 | EP1331972B1 Pharmaceutical compositions |
| 07/04/2007 | CN1993375A Steroid prodrugs with androgenic effect. |
| 07/04/2007 | CN1993351A Crystalline polymorph of pipindoxifene hydrochloride monohydrate |
| 07/04/2007 | CN1993123A Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof |
| 07/04/2007 | CN1990499A Further syntheses of cyproterone acetate |
| 07/04/2007 | CN1990474A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 07/04/2007 | CN1989954A Tartaric acid metoprolol sustained release capsules and its preparation method |
| 07/04/2007 | CN1324001C Novel thyroid receptor ligands |
| 07/04/2007 | CN1323658C Novel dry powder inhalation system for transpulmonary administration |
| 07/03/2007 | US7238811 Chemical compounds |
| 07/03/2007 | US7238809 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 07/03/2007 | US7238717 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis. |
| 07/03/2007 | US7238705 Aporphine esters and their use in therapy |
| 07/03/2007 | US7238699 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 07/03/2007 | US7238695 Imidazolyl derivatives |
| 07/03/2007 | US7238670 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 06/28/2007 | WO2007073555A1 Use of 4, 7-dihydrothieno [2, 3-b] pyridine compounds in the treatment of cardiovascular diseases |
| 06/28/2007 | WO2007072977A1 Pharmaceutical composition for allergic disease |
| 06/28/2007 | WO2006116526A3 Polymorph form ii of tanaproget |
| 06/28/2007 | US20070149492 Method of affecting sleep and sleep-related behaviors |
| 06/28/2007 | US20070148256 Pharmacologic-functioning water and usage of the same |
| 06/28/2007 | US20070148108 Stable vitamin b6 derivative |
| 06/28/2007 | CA2634158A1 Use of 4, 7-dihydrothieno ¬2, 3-b| pyridine compounds in the treatment of cardiovascular diseases |
| 06/27/2007 | EP1800689A1 Liquid preparation of physiologically active peptide |
| 06/27/2007 | EP1799715A1 Thyrotropin receptor preparations, binding regions thereof, antibody and hormone interactions therewith, and uses thereof |
| 06/27/2007 | EP1620392B1 Hydroxy-biphenyl-carbaldehyde oxime derivatives and their use as estrogenic agents |
| 06/27/2007 | EP1305419B1 Modulation by il-tif/interleukin-21 |
| 06/27/2007 | EP1144366B1 3,4-disubstituted acylanilide derivatives and their use as androgen receptor suppressors |
| 06/27/2007 | EP1107743B1 Stable spray-dried protein formulations |
| 06/27/2007 | CN1985919A Chinese medicine composition for treating facial stain and other endocrinic gynecopathy |
| 06/26/2007 | US7235628 Analogues of GLP-1 |
| 06/26/2007 | US7235565 Quinoline and quinolinones 4-substituted with a 3-(hetero)cyclylcarbonyl-1-imidazolinyl or 3-(hetero)cyclylcarbonyl-1-imidazolinonyl group; treating diabetes, glomerulonephritis, endotoxic shock, psoriasis, and arthritis |
| 06/26/2007 | US7235552 Cholenic acid amides and pharmaceutical compositions thereof |
| 06/26/2007 | US7235368 CHP for use as marker for sepsis-type inflammatory diseases |
| 06/26/2007 | CA2235686C Indolin-2-one derivatives, process for their production and the pharmaceutical compositions containing them |
| 06/21/2007 | WO2007069758A1 Composition having ppar ligand activity |
| 06/21/2007 | WO2007069744A1 Composition for prevention/amelioration of metabolic syndrome |
| 06/21/2007 | WO2007068948A2 Pharmaceutical sustained release compositions comprising in particular thyroid hormones |
| 06/21/2007 | WO2007068115A1 Method of detecting and reducing boar taint using nuclear receptors |
| 06/21/2007 | WO2007035355A3 Modulators of metabolism and the treatment of disorders related thereto |
| 06/21/2007 | US20070142381 Calcium receptor modulating agents |
| 06/21/2007 | US20070142379 Cyclohexyl derivatives as selective estrogen receptor modulators |
| 06/21/2007 | US20070142345 Steroids for cancer treatment |
| 06/21/2007 | US20070142334 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine |
| 06/21/2007 | CA2634006A1 Pharmaceutical sustained release compositions comprising liothyronine or the sodium salt of liothyronine |
| 06/21/2007 | CA2633296A1 Method of detecting and reducing boar taint using nuclear receptors |
| 06/21/2007 | CA2632607A1 Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes |
| 06/20/2007 | EP1798221A1 2-arylcarboxamide-nitrogeneous heterocycle compound |
| 06/20/2007 | EP1796664A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 06/20/2007 | EP1796643A1 Treatment of androgen - deprivation induced osteoporosis |
| 06/20/2007 | EP1715887B1 N-terminally monopegylated human growth hormone conjugates, process for their preparation, and use thereof |
| 06/20/2007 | EP1472351B1 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 06/20/2007 | EP1228231B1 Mammalian-type glycosylation in plants |
| 06/20/2007 | EP1105408B1 Congugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 06/20/2007 | CN1322002C Methylene-4-azasteroids |
| 06/20/2007 | CN1321688C Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 06/20/2007 | CN1321677C Chinese herbal medicine for curing hyperthyroidism |
| 06/19/2007 | CA2437468C Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus |
| 06/19/2007 | CA2281844C Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 06/14/2007 | WO2007067490A1 POLYMORPHS OF ANDROGEN RECEPTOR MODULATOR - (N-3H-IMIDAZO [4 , 5-B] PYRIDIN-2-YL-METHYL) -2-FLUORO-4-METHYL-3-OXO-4-AZA-ANDROST- l-EN-17 . BETA . -CARBOXAMIDE |
| 06/14/2007 | WO2007065942A2 Bis-heterocyclic imidazolyl compounds |
| 06/14/2007 | WO2007065726A1 11β-BENZALDOXIME DERIVATIVES OF D-HOMOOESTRA-4,9-DIEN-3-ONES |
| 06/14/2007 | WO2007044560A3 Modulators of atp-binding cassette transporters |
| 06/14/2007 | US20070135348 Methods and compositions for the treatment of peripheral artery disease |
| 06/14/2007 | US20070135335 Therapeutic molecules |
| 06/14/2007 | US20070134238 Modulation of T Cell Differentiation for the Treatment of T Helper Cell Mediated Diseases |
| 06/14/2007 | DE102005048483A1 Mittel zur Therapie und Prophylaxe des Diabetes mellitus Means for the therapy and prophylaxis of diabetes mellitus |
| 06/14/2007 | CA2631936A1 Polymorphs of androgen receptor modulator - (n-3h-imidazo [4 , 5-b] pyridin-2-yl-methyl) -2-fluoro-4-methyl-3-oxo-4-aza-androst- 1-en-17 . beta . -carboxamide |
| 06/14/2007 | CA2631364A1 11.beta.-benzaldoxime derivatives of d-homooestra-4,9-dien-3-ones |
| 06/14/2007 | CA2629137A1 Bis-heterocyclic imidazolyl compounds |
| 06/13/2007 | EP1795598A1 Novel peptides |
| 06/13/2007 | EP1794176A2 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 06/13/2007 | EP1793818A2 Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder |
| 06/13/2007 | EP1793816A2 Compositions for treating amyloid associated diseases |
| 06/13/2007 | EP1490065B1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors |
| 06/13/2007 | EP1444247B1 Tibolone formulations |
| 06/13/2007 | EP1214292B1 Tyrosine derivatives |
| 06/13/2007 | CN1980949A New 2-substituted d-homo-estra-1,3,5(10)-trienes as inhibitors of 17beta-hydroxy steroid dehydrogenase type 1 |
| 06/13/2007 | CN1980917A Novel indole derivatives as selective androgen receptor modulators (SARMS) |
| 06/13/2007 | CN1977948A Chinese medicine composition for treating high insulin polycystic ovary syndrome |
| 06/13/2007 | CN1977947A Chinesemedicine composition for treating high male hormone polycystic ovary syndrome |
| 06/13/2007 | CN1977862A Pre-formulation for the tabletting of natural mixtures of conjugated estrogens |
| 06/13/2007 | CN1321129C Inhibitors of caspases |
| 06/13/2007 | CN1320917C Dripping pills of 'Xiao Chaihu' |
| 06/12/2007 | US7230106 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 06/12/2007 | US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 06/12/2007 | US7229995 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 06/12/2007 | US7229990 E.g., tert-Butyl-5-amino-2-methylthio-4-(3-methoxyphenyl)-quinazoline-6 -carboxamide; used in fertility regulation therapies. |
| 06/12/2007 | US7229987 Oxazoles with one or more tertiary amine groups and phenyl groups, e.g., 1-{4-[2-(Benzofuran-2-ylmethoxymethyl)-oxazol-5-yl]-phenyl}-3-(2-dimethylamino-ethyl)-urea and -(3-{4-[2-(2-Phenoxy-ethylsulfanylmethyl)-oxazol-5-yl]-phenoxy}-propyl)-azepine; treating obesity and related diseases, e.g., diabetes |
| 06/12/2007 | US7229646 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| 06/12/2007 | CA2393758C Unsaturated 14,15-cyclopropano-androstanes |
| 06/07/2007 | WO2007065023A2 Processes for obtaining lignan extracts and compositions containing the lignan extracts |
| 06/07/2007 | WO2007062876A1 Prodrugs of er-beta-selective substances method for production thereof and pharmaceutical compositions comprising the same |
| 06/07/2007 | WO2007062874A2 Sulfamoyl sulfonate prodrugs |
| 06/07/2007 | WO2007062483A1 Increasing pregnancy rates |
| 06/07/2007 | US20070129348 Receptor antagonist |
| 06/07/2007 | US20070129285 Protein a compositions and methods of use |
| 06/07/2007 | US20070128603 Diagnostic and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 06/07/2007 | US20070128203 Anti-integrin antibodies, compositions, methods and uses |